HCC Staging and Treatment Options

Tuesday, April 1, 2025

1:15 PM – 2:30 PM CT

Location: Music City Center, 209 ABC

CE: 1.25

Content Level: 200 (intermediate)

Coordinator(s)

Edward Kim, MD (he/him/his)

Professor of Radiology and Surgery
Mount Sinai Health System, United States
Nora Tabori, MD (she/her/hers)

Associate Professor
MedStar Washington Hospital Center, United States

Understand the stages of the BCLC and the role of locoregional therapies play in each stage with review of current data

Understand the role of various locoregional therapies in the very early to early stage according to the BCLC.
Understand the role of locoregional therapy with or without systemic therapy for downstaging, as well as palliative treatment in the intermediate stage of HCC.
Understand the reasoning and literature behind the use of locoregional therapy with systemic therapy in the advanced stage of HCC.

1:15 PM – 1:25 PM CT

Overview of TACE and TARE in the Intermediate Stage
Speaker: Edward Kim, MD (he/him/his) – Mount Sinai Health System
1:25 PM – 1:35 PM CT

TACE in the Early Stage HCC
Speaker: Toshihiro Tanaka, MD, PhD (he/him/his) – Nara Medical University
1:35 PM – 1:45 PM CT

TARE for Downstaging and Palliative Intent for Intermediate Stage
Speaker: Nora Tabori, MD (she/her/hers) – MedStar Washington Hospital Center
1:45 PM – 1:55 PM CT

Radiation Segmentectomy for Very Early to Early Stage HCC
Speaker: Kirema Garcia-Reyes, MD – Mount Sinai
1:55 PM – 2:05 PM CT

Ablation for Very Early to Early Stage HCC
Speaker: Venkatesh P. Krishnasamy, MD (he/him/his) – University of Alabama at Birmingham
2:05 PM – 2:15 PM CT

Where Does TARE Fit in the Advanced Stage of HCC with Systemic Therapy?
Speaker: Beau B. Toskich, MD, FSIR – Department of Radiology, Division of Interventional Radiology, Mayo Clinic, Jacksonville, FL 32224, United States
2:15 PM – 2:30 PM CT

Q&A